×
DaVita Cash on Hand 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita cash on hand for the quarter ending June 30, 2024 was
$0.524B
, a
20.54% increase
year-over-year.
DaVita cash on hand for 2023 was
$0.476B
, a
14.29% increase
from 2022.
DaVita cash on hand for 2022 was
$0.417B
, a
27.82% decline
from 2021.
DaVita cash on hand for 2021 was
$0.577B
, a
10.61% increase
from 2020.
View More
DaVita Cash on Hand 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
DaVita cash on hand for 2023 was
$0.476B
, a
14.29% increase
from 2022.
DaVita cash on hand for 2022 was
$0.417B
, a
27.82% decline
from 2021.
DaVita cash on hand for 2021 was
$0.577B
, a
10.61% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$17.3B
Encompass Health (EHC)
$9.2B
Chemed (CHE)
$8.7B
Elanco Animal Health (ELAN)
$7.1B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$4.9B
Amedisys (AMED)
$3.2B
Astrana Health (ASTH)
$2.7B
LifeStance Health (LFST)
$2.6B
Addus HomeCare (ADUS)
$2.4B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$1B
Aveanna Healthcare Holdings (AVAH)
$1B
Atai Life Sciences (ATAI)
$215M
Daxor (DXR)
$46M
ATI Physical Therapy (ATIP)
$26M
MEDIROM Healthcare Technologies (MRM)
$19M
Psychemedics (PMD)
$14M
Ontrak (OTRK)
$10M
Novo Integrated Sciences (NVOS)
$5M
IMAC Holdings (BACK)
$2M